Rashid M, Omar M, Mohanta T
Database (Oxford). 2023; 2023.
PMID: 36929177
PMC: 10019025.
DOI: 10.1093/database/baad004.
Mohanta T, Kamran M, Omar M, Anwar W, Choi G
Sci Rep. 2022; 12(1):7421.
PMID: 35523906
PMC: 9076895.
DOI: 10.1038/s41598-022-11077-z.
Chen Y, Huang S, Tai M, Chen J, Liang C
J Biomed Sci. 2019; 26(1):72.
PMID: 31597574
PMC: 6784344.
DOI: 10.1186/s12929-019-0566-1.
Yang Y, Peng X, Ying P, Tian J, Li J, Ke J
Nucleic Acids Res. 2018; 47(D1):D874-D880.
PMID: 30215764
PMC: 6324025.
DOI: 10.1093/nar/gky821.
Wyroba E, Kwasniak P, Miller K, Kobylecki K, Osinska M
Eur J Histochem. 2016; 60(2):2612.
PMID: 27349314
PMC: 4933825.
DOI: 10.4081/ejh.2016.2612.
Glycerol-3-phosphate acyltransferase-1 upregulation by O-GlcNAcylation of Sp1 protects against hypoxia-induced mouse embryonic stem cell apoptosis via mTOR activation.
Lee H, Ryu J, Jung Y, Lee K, Kim D, Han H
Cell Death Dis. 2016; 7:e2158.
PMID: 27010859
PMC: 4823928.
DOI: 10.1038/cddis.2015.410.
Manipulation of the glycan-specific natural antibody repertoire for immunotherapy.
New J, King R, Kearney J
Immunol Rev. 2016; 270(1):32-50.
PMID: 26864103
PMC: 4755354.
DOI: 10.1111/imr.12397.
Three Decades of Research on O-GlcNAcylation - A Major Nutrient Sensor That Regulates Signaling, Transcription and Cellular Metabolism.
Hart G
Front Endocrinol (Lausanne). 2014; 5:183.
PMID: 25386167
PMC: 4209869.
DOI: 10.3389/fendo.2014.00183.
Triptolide-induced cell death in pancreatic cancer is mediated by O-GlcNAc modification of transcription factor Sp1.
Banerjee S, Sangwan V, McGinn O, Chugh R, Dudeja V, Vickers S
J Biol Chem. 2013; 288(47):33927-33938.
PMID: 24129563
PMC: 3837133.
DOI: 10.1074/jbc.M113.500983.
O-GlcNAcylation-inducing treatments inhibit estrogen receptor α expression and confer resistance to 4-OH-tamoxifen in human breast cancer-derived MCF-7 cells.
Kanwal S, Fardini Y, Pagesy P, NTumba-Byn T, Pierre-Eugene C, Masson E
PLoS One. 2013; 8(7):e69150.
PMID: 23935944
PMC: 3730543.
DOI: 10.1371/journal.pone.0069150.
The role of intracellular protein O-glycosylation in cell adhesion and disease.
Bektas M, Rubenstein D
J Biomed Res. 2013; 25(4):227-36.
PMID: 23554695
PMC: 3597071.
DOI: 10.1016/S1674-8301(11)60031-6.
Role of transcription factor modifications in the pathogenesis of insulin resistance.
Kim M, Bae J, Kim T, Park J, Ahn Y
Exp Diabetes Res. 2011; 2012:716425.
PMID: 22110478
PMC: 3205681.
DOI: 10.1155/2012/716425.
Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease.
Hart G, Slawson C, Ramirez-Correa G, Lagerlof O
Annu Rev Biochem. 2011; 80:825-58.
PMID: 21391816
PMC: 3294376.
DOI: 10.1146/annurev-biochem-060608-102511.
Muscle-specific overexpression of NCOATGK, splice variant of O-GlcNAcase, induces skeletal muscle atrophy.
Huang P, Ho S, Wang K, Roessler B, Zhang F, Hu Y
Am J Physiol Cell Physiol. 2010; 300(3):C456-65.
PMID: 21178104
PMC: 3063975.
DOI: 10.1152/ajpcell.00124.2010.
Cytoskeletal keratin glycosylation protects epithelial tissue from injury.
Ku N, Toivola D, Strnad P, Omary M
Nat Cell Biol. 2010; 12(9):876-85.
PMID: 20729838
PMC: 3549664.
DOI: 10.1038/ncb2091.
O-GlcNAc signaling in the cardiovascular system.
Ngoh G, Facundo H, Zafir A, Jones S
Circ Res. 2010; 107(2):171-85.
PMID: 20651294
PMC: 2919351.
DOI: 10.1161/CIRCRESAHA.110.224675.
Regulation of insulin receptor substrate 1 (IRS-1)/AKT kinase-mediated insulin signaling by O-Linked beta-N-acetylglucosamine in 3T3-L1 adipocytes.
Whelan S, Dias W, Thiruneelakantapillai L, Lane M, Hart G
J Biol Chem. 2009; 285(8):5204-11.
PMID: 20018868
PMC: 2820748.
DOI: 10.1074/jbc.M109.077818.
O-GlcNAcylation enhances FOXO4 transcriptional regulation in response to stress.
Ho S, Wang K, Whisenhunt T, Huang P, Zhu X, Kudlow J
FEBS Lett. 2009; 584(1):49-54.
PMID: 19932102
PMC: 2802345.
DOI: 10.1016/j.febslet.2009.11.059.
Glutamine enhances heat shock protein 70 expression via increased hexosamine biosynthetic pathway activity.
Hamiel C, Pinto S, Hau A, Wischmeyer P
Am J Physiol Cell Physiol. 2009; 297(6):C1509-19.
PMID: 19776393
PMC: 2793053.
DOI: 10.1152/ajpcell.00240.2009.
Glucosamine suppresses proliferation of human prostate carcinoma DU145 cells through inhibition of STAT3 signaling.
Chesnokov V, Sun C, Itakura K
Cancer Cell Int. 2009; 9:25.
PMID: 19744341
PMC: 2747838.
DOI: 10.1186/1475-2867-9-25.